CMS Posts Final Payment Determination for bioAffinity Techno

SAN ANTONIO - bioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other lung diseases, today announced that the...

Related Keywords

United States , American , Julie Anne Overton , Maria Zannes , While The Company , University Of Texas At San Antonio , Centers For Medicare , Medicare Clinical Lab Fee Schedule , Affinity Technologies Inc , Company Annual Report On Form , American Medical Association , Medicare Advisory Panel On Clinical Diagnostic Laboratory , Medicare Advisory Panel , Laboratory Developed Test , Medicaid Services , Precision Pathology Laboratory Services , Nasdaq , Laboratory Analyses , Affinity Technologies , Cypath Lung , Affinity Technologies President , Advisory Panel , Clinical Diagnostic Laboratory Tests , Current Procedural Terminology , Clinical Lab Fee Schedule , Medical Association , Path Lung , Annual Report , News Publishing , Markets ,